Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the

Xiu-Fang Wang1, Paul K Witting, Brian A Salvatore

  • 1Apoptosis Research Group, School of Health Science, Griffith University, Southport, Qld, Australia.

Insights

Alpha-tocopheryl succinate (alpha-TOS), a vitamin E analog, effectively induces cancer cell death (apoptosis) in breast cancer cells, regardless of HER2/erbB2 protein levels. This finding is significant for developing new cancer treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Vitamin E (VE) analogs, like alpha-tocopheryl succinate (alpha-TOS), exhibit anti-neoplastic properties.
  • HER2/erbB2 overexpression is common in breast cancers, contributing to treatment resistance.

Purpose of the Study:

  • To investigate the efficacy of alpha-TOS and novel VE analogs in inducing apoptosis in breast cancer cells with varying HER2/erbB2 expression levels.
  • To elucidate the mechanisms underlying VE analog-induced apoptosis in breast cancer cells.

Main Methods:

  • Treatment of breast cancer cells (erbB2-low and -high) with alpha-TOS and VE analogs.
  • Assessment of apoptosis, reactive oxygen species (ROS) generation, and mitochondrial membrane potential (DeltaPsi(m)).
  • Use of superoxide dismutase, mitochondrially targeted coenzyme Q, and rho(0) cells to confirm mechanisms.

Main Results:

  • Alpha-TOS and VE analogs induced apoptosis comparably in both erbB2-low and -high cells.
  • Apoptosis was preceded by ROS generation and mitochondrial destabilization (DeltaPsi(m) dissipation).
  • Mitochondrial dependence and radical generation were confirmed as critical for VE analog-mediated apoptosis.

Conclusions:

  • Alpha-tocopheryl succinate effectively induces apoptosis in breast cancer cells irrespective of HER2/erbB2 expression.
  • The findings suggest alpha-TOS as a potential therapeutic agent for breast cancers, including those resistant to conventional treatments due to HER2/erbB2 overexpression.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...